EXAS, SRPT, and UTHR make up the SPDR S&P Biotech ETF (XBI) top holdings
In June, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month. XBI proceeded to rattle off a 4% win for June and is up 7.3% in July already. Where do the ETF’s top holdings stand?
The shares of EXACT Sciences Corporation (NASDAQ:EXAS) are down 1.1% to trade at $49.14 today. Despite bouncing 21% off its June 25 annual lows of $40.62, the cancer diagnostics stock is 33.5% lower in 2024.
Sarepta Therapeutics Inc (NASDAQ:SRPT) stock is 1.8% lower to trade at $146.16 at last check. The shares have taken a 15.5% haircut off their June 21 annual high of $173.25, but remain up 51.6% year-to-date.
United Therapeutics Corp. (NASDAQ:UTHR) stock is a powerhouse, hitting a record high of $339.56 today after a price-target hike from Leerink to $344 from $338. Up 1.6% at $333.44 at last glance, UTHR has tacked on 51.6% in 2024.